ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 60 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $52,200,000 | +92.3% | 630,282 | +54.0% | 0.34% | -1.2% |
| Q1 2021 | $27,143,000 | -67.0% | 409,341 | -61.8% | 0.34% | -61.1% |
| Q4 2020 | $82,164,000 | +4113.5% | 1,070,814 | +3383.7% | 0.88% | +2161.5% |
| Q4 2019 | $1,950,000 | +125.2% | 30,738 | 0.0% | 0.04% | +69.6% |
| Q3 2019 | $866,000 | -90.1% | 30,738 | -90.7% | 0.02% | -88.6% |
| Q2 2019 | $8,765,000 | +44.4% | 330,738 | 0.0% | 0.20% | +17.5% |
| Q1 2019 | $6,069,000 | +69.4% | 330,738 | +10.2% | 0.17% | +25.7% |
| Q4 2018 | $3,582,000 | -48.9% | 300,000 | -17.9% | 0.14% | -27.3% |
| Q3 2018 | $7,006,000 | +41.0% | 365,445 | 0.0% | 0.19% | +43.8% |
| Q2 2018 | $4,970,000 | +88.6% | 365,445 | 0.0% | 0.13% | +75.7% |
| Q1 2018 | $2,635,000 | +92.1% | 365,445 | -56.9% | 0.07% | +7.2% |
| Q2 2017 | $1,372,000 | -12.4% | 847,458 | 0.0% | 0.07% | -22.5% |
| Q1 2017 | $1,567,000 | +19.3% | 847,458 | 0.0% | 0.09% | -4.3% |
| Q4 2016 | $1,313,000 | -78.9% | 847,458 | 0.0% | 0.09% | -76.9% |
| Q3 2016 | $6,228,000 | – | 847,458 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |